Biblio

Export 141 results:
Author Keyword Title [ Type(Desc)] Year
Filters: Keyword is Animals  [Clear All Filters]
Journal Article
M. T. Fodero-Tavoletti, Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C. A., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G., Gong, S., Adlard, P. A., Barnham, K. J., Rowe, C. C., Masters, C. L., Kudo, Y., Cappai, R., Yanai, K., and Villemagne, V. L., 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease., Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
C. D. Pereira, Martins, F., Wiltfang, J., Silva, O. A. B. da Cru, and Rebelo, S., ABC Transporters Are Key Players in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 463-485, 2018.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype., J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
T. Minh Do, Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. - M., Farinotti, R., and Bourasset, F., Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD)., J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.
J. L. King, Wong, A. A., and Brown, R. E., Age-Related Changes in the Spatial Frequency Threshold of Male and Female 3xTg-AD Mice Using OptoMotry., J Alzheimers Dis, vol. 62, no. 2, pp. 591-596, 2018.
Y. Shan, Wang, D. - D., Xu, Y. - X., Wang, C., Cao, L., Liu, Y. - S., and Zhu, C. - Q., Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid., J Alzheimers Dis, vol. 49, no. 3, pp. 829-44, 2016.
U. Rüb, Stratmann, K., Heinsen, H., Seidel, K., Bouzrou, M., and Korf, H. - W., Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches., J Alzheimers Dis, vol. 57, no. 3, pp. 683-696, 2017.
D. Zádori, Veres, G., Szalárdy, L., Klivenyi, P., and Vecsei, L., Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines., J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta., Neuron, vol. 78, no. 4, pp. 631-43, 2013.
S. K. Singhrao, Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S. J., Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
J. A. Snir, Suchy, M., Bindseil, G. A., Kovacs, M., Chronik, B. A., Hudson, R. H. E., Pasternak, S. H., and Bartha, R., An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 61, no. 3, pp. 1241-1252, 2018.
A. Suzuki, Stern, S. A., Bozdagi, O., Huntley, G. W., Walker, R. H., Magistretti, P. J., and Alberini, C. M., Astrocyte-neuron lactate transport is required for long-term memory formation., Cell, vol. 144, no. 5, pp. 810-23, 2011.
F. Nafar, J Williams, B., and Mearow, K. M., Astrocytes release HspB1 in response to amyloid-β exposure in vitro., J Alzheimers Dis, vol. 49, no. 1, pp. 251-63, 2016.
S. Eketjäll, Janson, J., Kaspersson, K., Bogstedt, A., Jeppsson, F., Fälting, J., Haeberlein, S. Budd, Kugler, A. R., Alexander, R. C., and Cebers, G., AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics., J Alzheimers Dis, vol. 50, no. 4, pp. 1109-23, 2016.
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine., J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
M. A. Burguillos, Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., and Joseph, B., Caspase signalling controls microglia activation and neurotoxicity., Nature, vol. 472, no. 7343, pp. 319-24, 2011.
E. Vallino Costassa, Fiorini, M., Zanusso, G., Peletto, S., Acutis, P., Baioni, E., Maurella, C., Tagliavini, F., Catania, M., Gallo, M., Faro, M. Lo, Chieppa, M. Novella, Meloni, D., D'Angelo, A., Paciello, O., Ghidoni, R., Tonoli, E., Casalone, C., and Corona, C., Characterization of Amyloid-β Deposits in Bovine Brains., J Alzheimers Dis, vol. 51, no. 3, pp. 875-87, 2016.
D. E. Moss, Perez, R. G., and Kobayashi, H., Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates., J Alzheimers Dis, vol. 55, no. 3, pp. 1285-1294, 2017.
H. Qiu, Zhong, R., Liu, H., Zhang, F., Li, S., and Le, W., Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice., J Alzheimers Dis, vol. 50, no. 3, pp. 669-85, 2016.
K. Nunez, Kay, J., Krotow, A., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 151-63, 2016.
K. R. LeVault, Tischkau, S. A., and Brewer, G. J., Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 49, no. 2, pp. 301-16, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
J. Cummings, Ritter, A., and Zhong, K., Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future., J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
C. M. Huber, Yee, C., May, T., Dhanala, A., and Mitchell, C. S., Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy., J Alzheimers Dis, vol. 61, no. 1, pp. 265-281, 2018.

Pages